Published in:
01-04-2022 | Disorders of Intellectual Development | Brief Communication
Identification of a novel de novo mutation in the CTNNB1 gene in an Iranian patient with intellectual disability
Authors:
Sepide Dashti, Shadab Salehpour, Mohammad-Reza Ghasemi, Hossein Sadeghi, Masoumeh Rostami, Farzad Hashemi-Gorji, Reza Mirfakhraie, Vahid Reza Yassaee, Mohammad Miryounesi
Published in:
Neurological Sciences
|
Issue 4/2022
Login to get access
Abstract
CTNNB1 encodes for the β-catenin protein, a component of the cadherin adhesion complex, which regulates cell–cell adhesion and gene expression in the canonical Wnt signaling pathway. Mutations in CTNNB1 have been reported to be associated with cancer and mental disorders. Recently, loss-of-function mutations in CTNNB1 have been observed in patients with intellectual disability and some other clinical manifestations including motor and language delays, microcephaly, and mild visual defects. We report an 8-year-old Iranian girl with intellectual disability, hypotonia, impaired vision such as vitreomacular adhesion, motor delay, and speech delay. A novel, de novo nonsense mutation (c.1014G > A; p.Trp338Ter) in exon 7 of the CTNNB1 (NM_001904) gene was detected and confirmed by whole-exome sequencing and Sanger sequencing, respectively. This study helps to expand the growing list of loss-of-function mutations known in the CTNNB1 gene.